What is the difference between ALCAFTADINE and RANITIDINE?

ALCAFTADINE and RANITIDINE are both H2 Blockers, so they work through the same broad mechanism. They differ in dosing, half-life, side-effect frequency, and how individual patients tolerate them. See the head-to-head sections below for the specifics.

Can ALCAFTADINE and RANITIDINE be used for the same conditions?

Both medications are prescribed for overlapping indications including See full prescribing information. Always verify with your prescriber and the current FDA label before switching.

Is LASTACAFT the same as RANITIDINE?

No. LASTACAFT (ALCAFTADINE) and RANITIDINE (RANITIDINE) are distinct medications. They are sometimes confused because of similar branding or because they treat overlapping conditions, but they have different active ingredients and different safety profiles.

Which has fewer side effects, ALCAFTADINE or RANITIDINE?

Side-effect frequency varies by individual. The side-effect comparison section on this page shows FAERS-reported events for each drug side by side. FAERS is voluntary reporting, so it reflects what patients and clinicians chose to report, not absolute population risk.

Can I switch from ALCAFTADINE to RANITIDINE?

Switching medications should always be done under prescriber supervision. The "patient stories" section on this page includes accounts from people who have made the switch and what their transition felt like, but those are individual experiences, not protocols.

ALCAFTADINE vs RANITIDINE

Compare ALCAFTADINE (LASTACAFT) and RANITIDINE (RANITIDINE) — clinical data, side effects, and patient experiences.

ALCAFTADINE

LASTACAFT · H2 Blocker

How it works

12.1 Mechanism of Action Alcaftadine is an H 1 histamine receptor antagonist and inhibitor of the release of histamine from mast cells. Decreased chemotaxis and inhibition of eosin...

Approved for

See full prescribing information

OphthalmicTablet

RANITIDINE

RANITIDINE · H2 Blocker

How it works

Other agent

Approved for

Zollinger-Ellison syndrome and systemic mastocytosis). Short-term treatment of active

150 mg twice daily. Treatment of endoscopically diagnosed erosive esophagitis. Symptomatic relief of heartburn commonly occurs within 24 hours of therapy initiation with Ranitidine Tablets USP

active

benign gastric ulcer

OralTablet

Quick Comparison

ALCAFTADINERANITIDINE

Drug Class

H2 Blocker

Route

Ophthalmic

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

ALCAFTADINE

Drug Not Working

1-10%

Headache

0.1-1%

Blurred Vision

0.1-1%

RANITIDINE

Nausea

0.1-1%

Fatigue

0.1-1%

Drug Not Working

0.1-1%

FDA Warnings

ALCAFTADINE

5 WARNINGS AND PRECAUTIONS • Potential for Eye Injury and Contamination : To minimize the risk of eye injury and contamination, do not touch dropper tip to eyelids and surrounding areas, or any other surface

RANITIDINE

No specific warnings

Clinical Trial Data

No head-to-head clinical studies found for ALCAFTADINE vs RANITIDINE.

ALCAFTADINE vs RANITIDINE: What You Should Know

Key Differences

Both ALCAFTADINE and RANITIDINE belong to the H2 Blocker class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. ALCAFTADINE is administered via Ophthalmic, whereas RANITIDINE uses Oral. Route of administration can affect onset of action and patient adherence.

Safety Considerations

ALCAFTADINE carries 1 FDA warning. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

ALCAFTADINE vs FAMOTIDINE→ALCAFTADINE vs CIMETIDINE→ALCAFTADINE vs IBUPROFEN AND FAMOTIDINE→ALCAFTADINE vs DESLORATADINE→ALCAFTADINE vs DESLORATADINE AND PSEUDOEPHEDRINE SULFATE→ALCAFTADINE vs NIZATIDINE→

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

ALCAFTADINE: DailyMed label · FAERS adverse events · ClinicalTrials.gov
RANITIDINE: DailyMed label · FAERS adverse events · ClinicalTrials.gov

Loading comparison data...

ALCAFTADINE vs RANITIDINE

Compare ALCAFTADINE (LASTACAFT) and RANITIDINE (RANITIDINE) — clinical data, side effects, and patient experiences.

ALCAFTADINE

LASTACAFT · H2 Blocker

How it works

12.1 Mechanism of Action Alcaftadine is an H 1 histamine receptor antagonist and inhibitor of the release of histamine from mast cells. Decreased chemotaxis and inhibition of eosin...

Approved for

See full prescribing information

OphthalmicTablet

RANITIDINE

RANITIDINE · H2 Blocker

How it works

Other agent

Approved for

Zollinger-Ellison syndrome and systemic mastocytosis). Short-term treatment of active

150 mg twice daily. Treatment of endoscopically diagnosed erosive esophagitis. Symptomatic relief of heartburn commonly occurs within 24 hours of therapy initiation with Ranitidine Tablets USP

active

benign gastric ulcer

OralTablet

Quick Comparison

ALCAFTADINERANITIDINE

Drug Class

H2 Blocker

Route

Ophthalmic

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

ALCAFTADINE

Drug Not Working

1-10%

Headache

0.1-1%

Blurred Vision

0.1-1%

RANITIDINE

Nausea

0.1-1%

Fatigue

0.1-1%

Drug Not Working

0.1-1%

FDA Warnings

ALCAFTADINE

5 WARNINGS AND PRECAUTIONS • Potential for Eye Injury and Contamination : To minimize the risk of eye injury and contamination, do not touch dropper tip to eyelids and surrounding areas, or any other surface

RANITIDINE

No specific warnings

Clinical Trial Data

No head-to-head clinical studies found for ALCAFTADINE vs RANITIDINE.

ALCAFTADINE vs RANITIDINE: What You Should Know

Key Differences

Safety Considerations

ALCAFTADINE carries 1 FDA warning. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.